NCT00346164 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 0%
Ineligible patients and patients who were not treated based on the protocol were excluded from AE reporting (both serious and other).
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Arm A: No Adjuvant Treatment | 0 / 205 | 0 / 205 | Not reported / Not reported |
| Arm B: Low Risk; Adjuvant Radiotherapy | 1 / 17 | 0 / 17 | Not reported / Not reported |
| Arm C: Intermediate & High Risk; Adjuvant Chemoradiotherapy | 1 / 110 | 2 / 110 | Not reported / Not reported |
| Arm D: Intermediate & High Risk; Neoadjuvant Chemoradiotherapy | 3 / 196 | 7 / 196 | Not reported / Not reported |
Serious adverse events
- organ System
- General disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Death NOS
- organ System
- Infections and infestations
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Infections and infestations - Other, specify
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 196
- num Events
- 0
- term
- Treatment related secondary malignancy
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 196
- num Events
- 0
- term
- Upper gastrointestinal hemorrhage
Other reported adverse events
- organ System
- Cardiac disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Cardiac disorders - Other, specify
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Dermatitis radiation
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Diarrhea
- organ System
- Nervous system disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Encephalopathy
- organ System
- General disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- General disorders and administration site conditions - Other, specify
- organ System
- Infections and infestations
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hepatic infection
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hypokalemia
- organ System
- Vascular disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hypotension
- organ System
- Cardiac disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Pericardial effusion
- organ System
- Nervous system disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Seizure
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Skin ulceration
- organ System
- Vascular disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Thromboembolic event
Complete source fields
- description
- Ineligible patients and patients who were not treated based on the protocol were excluded from AE reporting (both serious and other).
- event Groups
- description
- Patients with low-grade tumor with either negative or positive microscopic margins or high-grade tumor ≤ 5 cm (in maximum diameter) with negative microscopic margins are assigned to arm A: (observation only). clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 205
- serious Num Affected
- 0
- serious Num At Risk
- 205
- title
- Arm A: No Adjuvant Treatment
- description
- Patients with high-grade tumor ≤ 5 cm (in maximum diameter) with positive microscopic margins are assigned to arm B: (adjuvant radiotherapy). Beginning between 6-42 days after surgical resection, patients undergo a total of 31 fractions of adjuvant radiotherapy. clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy
- id
- EG001
- other Num Affected
- 0
- other Num At Risk
- 17
- serious Num Affected
- 1
- serious Num At Risk
- 17
- title
- Arm B: Low Risk; Adjuvant Radiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with high-grade, grossly resected primary tumor, with metastases are assigned to receive arm C: (adjuvant chemoradiotherapy). Patients receive ifosfamide IV; doxorubicin hydrochloride IV; beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- EG002
- other Num Affected
- 2
- other Num At Risk
- 110
- serious Num Affected
- 1
- serious Num At Risk
- 110
- title
- Arm C: Intermediate & High Risk; Adjuvant Chemoradiotherapy
- description
- High risk \[metastatic, resected, incompletely resected, or unresected disease\] patients with unresected, high-grade metastatic tumor are assigned to receive treatment as in arm D: (neoadjuvant chemoradiotherapy, surgery, and adjuvant chemotherapy with or without radiotherapy): Patients receive ifosfamide IV; doxorubicin hydrochloride IV. Beginning in week 4, patients also undergo a total of 31 fractions of radiotherapy. Patients undergo surgical resection in week 13. doxorubicin hydrochloride: Given IV clinical observation: Patients undergo observation therapeutic conventional surgery: Patients undergo surgery 3-dimensional conformal radiation therapy: Patients undergo radiotherapy ifosfamide: Given IV
- id
- EG003
- other Num Affected
- 7
- other Num At Risk
- 196
- serious Num Affected
- 3
- serious Num At Risk
- 196
- title
- Arm D: Intermediate & High Risk; Neoadjuvant Chemoradiotherapy
- frequency Threshold
- 0
- other Events
- organ System
- Cardiac disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Cardiac disorders - Other, specify
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Dermatitis radiation
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Diarrhea
- organ System
- Nervous system disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Encephalopathy
- organ System
- General disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- General disorders and administration site conditions - Other, specify
- organ System
- Infections and infestations
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hepatic infection
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hypokalemia
- organ System
- Vascular disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Hypotension
- organ System
- Cardiac disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Pericardial effusion
- organ System
- Nervous system disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Seizure
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Skin ulceration
- organ System
- Vascular disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Thromboembolic event
- serious Events
- organ System
- General disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Death NOS
- organ System
- Infections and infestations
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Infections and infestations - Other, specify
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 196
- num Events
- 1
- term
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
- organ System
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 110
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 196
- num Events
- 0
- term
- Treatment related secondary malignancy
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCv4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 205
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 110
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 196
- num Events
- 0
- term
- Upper gastrointestinal hemorrhage
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle